Update on pathological gambling

被引：21

作者：

Grant J.E. ^{[1
]}

Williams K.A. ^{[1
]}

Kim S.W. ^{[1
]}

机构：

[1] Department of Psychiatry, University of Minnesota, School of Medicine, Minneapolis, MN 55454

来源：

Current Psychiatry Reports | 2006年 / 8卷 / 1期

关键词：

Cocaine; Paroxetine; Naltrexone; Pathological Gambling; Gambling Behavior;

D O I：

10.1007/s11920-006-0081-4

中图分类号：

学科分类号：

摘要：

Pathological gambling (PG) is a significant public health concern associated with high rates of psychiatric comorbidity and mortality. Although research into the biology of PG is still in an early stage, recent advances in our understanding of motivation, reward, and addiction have provided substantial insight into the possible pathophysiology of this disorder. In addition, over the past 5 years, extraordinary progress has been made in the area of clinical research examining treatments for PG. Although PG is a disabling disorder that continues to represent a clinical challenge for the healthcare professional, our current knowledge of pharmacotherapy and psychosocial interventions offers potentially effective treatment options. Copyright © 2006 by Current Science Inc.

引用

页码：53 / 58

页数：5

共 46 条

[31]

Shah K.R., Potenza M.N., Eisen S.A., Biological basis for pathological gambling, Pathological Gambling: A Clinical Guide to Treatment, (2004)

[32]

Dodd M.L., Klos K.J., Bower J.H., Et al., Pathological gambling caused by drugs used to treat Parkinson disease, Arch Neurol, 62, pp. 1377-1381, (2005)

[33]

Hollander E., DeCaria C.M., Finkell J.N., Et al., A randomized double-blind fluvox- amine/placebo crossover trial in pathological gambling, Biol Psychiatry, 47, pp. 813-817, (2000)

[34]

Blanco C., Petkova E., Ibanez A., Et al., A pilot placebo-controlled study of fluvoxamine for pathological gambling, Ann Clin Psychiatry, 14, pp. 9-15, (2002)

[35]

Kim S.W., Grant J.E., Adson D.E., Et al., A double-blind placebo-controlled study of the efficacy and safety of paroxetine in the treatment of pathological gambling, J Clin Psychiatry, 63, pp. 501-507, (2002)

[36]

Grant J.E., Kim S.W., Potenza M.N., Et al., Paroxetine treatment of pathological gambling: A multi-center randomized controlled trial, Int Clin Psychopharmacol, 18, pp. 243-249, (2003)

[37]

Saiz-Ruiz J., Blanco C., Ibnaez A., Et al., Sertraline treatment of pathological gambling: A pilot study, J Clin Psychiatry, 66, pp. 28-33, (2005)

[38]

Potenza M.N., The neurobiology of pathological gambling, Semin Clin Neuropsychiatry, 6, pp. 217-226, (2001)

[39]

Hollander E., Pallanti S., Allen A., Et al., Does sustained-release lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders?, Am J Psychiatry, 162, pp. 137-145, (2005)

[40]

Kim S.W., Grant J.E., Adson D., Shin Y.C., Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling, Biol Psychiatry, 49, pp. 914-921, (2001)

← 1 2 3 4 5 →